Elevated preoperative serum levels of PD-L1 are indicative of a poor response to VEGF-targeted therapy and suggest an unfavorable prognosis in renal cell carcinoma (69). The gene discussed is CD274; the disease is hereditary clear cell renal cell carcinoma.